ACHN
Achillion Pharmaceuticals, Inc.
ACHN
ACHN
Delisted
ACHN was delisted on the 27th of January, 2020.
122 hedge funds and large institutions have $402M invested in Achillion Pharmaceuticals, Inc. in 2019 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 43 increasing their positions, 32 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
122
Holders Change
+8
Holders Change %
+7.02%
% of All Funds
2.68%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
21
Increased
43
Reduced
32
Closed
13
Calls
$1.94M
Puts
$854K
Net Calls
+$1.09M
Net Calls Change
+$950K
Top Buyers
| 1 |
BC
Boxer Capital
San Diego,
California
|
+$7.2M |
| 2 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$3.15M |
| 3 |
Renaissance Technologies
New York
|
+$3.04M |
| 4 |
PVI
Pura Vida Investments
New York
|
+$2.04M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.29M |
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$4.22M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$3.89M |
| 3 |
Millennium Management
New York
|
-$3.75M |
| 4 |
D.E. Shaw & Co
New York
|
-$1.97M |
| 5 |
Man Group
London,
United Kingdom
|
-$1.73M |
